A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.
about
The Relations between EGFR R521K Polymorphism and Risk of Cancer: Need for Clarification of Data in a Recent Meta-AnalysisEvaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.Screening of pharmacogenetic variants associated with drug sensitivity in patients with papillary thyroid carcinoma using next generation sequencing
P2860
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.
@ast
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.
@en
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.
@nl
type
label
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.
@ast
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.
@en
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.
@nl
prefLabel
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.
@ast
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.
@en
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.
@nl
P2093
P2860
P356
P1476
A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.
@en
P2093
P2860
P304
P356
10.1155/2014/312102
P577
2014-10-21T00:00:00Z